Research Topics
| I V BassettSummaryAffiliation: Massachusetts General Hospital Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIVIngrid V Bassett
Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
Clin Infect Dis 39:395-401. 2004....
Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South AfricaIngrid V Bassett
Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts, USA
Clin Infect Dis 51:823-9. 2010..Our objective was to assess the yield and cost of a more intensive tuberculosis screening in HIV-infected patients starting antiretroviral therapy (ART) in Durban, South Africa...- Screening for acute HIV infection in South Africa: finding acute and chronic diseaseI V Bassett
Division of General Medicine, Massachusetts General Hospital, Boston, MA, USA
HIV Med 12:46-53. 2011..Our objective was to evaluate the strategy of using pooled HIV plasma RNA to diagnose acute HIV infection in patients with negative or discordant rapid HIV antibody tests in Durban, South Africa... - Integrating HIV screening into routine health care in resource-limited settingsIngrid V Bassett
Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
Clin Infect Dis 50:S77-84. 2010..We review the benefits of knowledge of HIV serostatus and evidence from multiple countries surrounding the successes and pitfalls of provider-initiated testing in health care and home-based settings... - Who starts antiretroviral therapy in Durban, South Africa?... not everyone who shouldIngrid V Bassett
Division of Infectious Disease, Massachusetts General Hospital, Boston, MA 02114, USA
AIDS 24:S37-44. 2010..To evaluate rates of antiretroviral therapy (ART) initiation within 12 months of a new HIV diagnosis in Durban, South Africa... - Loss to care and death before antiretroviral therapy in Durban, South AfricaIngrid V Bassett
Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA
J Acquir Immune Defic Syndr 51:135-9. 2009..To examine the loss to care and mortality rates before starting antiretroviral therapy (ART) among ART eligible HIV-infected patients in Durban, South Africa. Design: Retrospective cohort study... - Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South AfricaIngrid V Bassett
Division of Infectious Disease, Massachusetts General Hospital, Boston, USA
J Acquir Immune Defic Syndr 59:25-30. 2012..To quantify the impact of tuberculosis (TB) co-infection on death and loss to follow-up (LTFU) 12 months after entry into an ART program... - Routine voluntary HIV testing in Durban, South Africa: the experience from an outpatient departmentIngrid V Bassett
Division of Infectious Disease, Massachusetts General Hospital, Boston, MA 02114, USA
J Acquir Immune Defic Syndr 46:181-6. 2007..To evaluate the yield of a routine voluntary HIV testing program compared with traditional provider-referred voluntary counseling and testing (VCT) in a hospital-affiliated outpatient department (OPD) in Durban, South Africa... - HIV/AIDS: AIDS Drug Assistance Programs in the era of routine HIV testingIngrid V Bassett
Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
Clin Infect Dis 47:695-701. 2008.... - Routine, voluntary HIV testing in Durban, South Africa: correlates of HIV infectionI V Bassett
Division of Infectious Disease, Massachusetts General Hospital, Boston, MA 02114, USA
HIV Med 9:863-7. 2008..Routine HIV testing is increasingly recommended in resource-limited settings. Our objective was to evaluate factors associated with a new diagnosis of HIV infection in a routine HIV testing programme in South Africa... - When to start antiretroviral therapy in resource-limited settingsRochelle P Walensky
Massachusetts General Hospital, Brigham and Women s Hospital, Harvard University Medical School, Harvard School of Public Health, and Boston University School of Public Health, Boston, Massachusetts 02114, USA
Ann Intern Med 151:157-66. 2009..The results of international clinical trials that are assessing when to initiate antiretroviral therapy (ART) will not be available for several years... - The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South AfricaElena Losina
Division of General Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America
PLoS ONE 5:e9538. 2010..Our objective was to determine PTLC in newly identified HIV-infected individuals in South Africa... - Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysisAndrea L Ciaranello
The Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
Clin Infect Dis 49:1915-27. 2009..We sought to derive pooled estimates of the 12-month rate of virologic suppression (HIV RNA, <400 copies/mL) and gain in CD4 cell percentage (DeltaCD4%) for children initiating ART in resource-limited settings... - Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DCRochelle P Walensky
Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
Clin Infect Dis 51:392-400. 2010..We forecast outcomes of this approach if implemented in Washington DC... - Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysisFrancisco M Marty
Division of Infectious Diseases, Boston, MA 02115, USA
Blood 110:490-500. 2007..66; P = .14 and P = .35, respectively). The protective effect of sirolimus-containing GVHD prophylaxis regimens on CMV reactivation should be confirmed in randomized trials... - The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South AfricaRochelle P Walensky
Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
J Acquir Immune Defic Syndr 56:26-35. 2011..Although 900,000 HIV-infected South Africans receive antiretroviral therapy, the majority of South Africans with HIV remain undiagnosed... - First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trialAndrea L Ciaranello
Division of Infectious Disease, Massachusetts General Hospital, Boston, 02114, USA
AIDS 25:479-92. 2011..nevirapine-based antiretroviral therapy (ART) among women previously exposed to single-dose nevirapine to prevent mother-to-child HIV transmission. However, lopinavir/ritonavir is 12 times costlier than nevirapine... - Home testing for HIV infection in resource-limited settingsIshani Ganguli
Division of General Medicine, Massachusetts General Hospital, 9th Floor, Boston, MA 02114, USA
Curr HIV/AIDS Rep 6:217-23. 2009..Home testing is showing promising early results in some high-prevalence, resource-limited settings. This article reviews the mechanisms and literature to date of this door-to-door approach...
Research Grants
- The Efficacy and Impact of Routine HIV and TB Testing in Durban, South AfricaINGRID BASSETT; Fiscal Year: 2007....
- Linkage & Retention: A Randomized Trial to Optimize HIV/TB Care in South AfricaINGRID VALERIE BASSETT; Fiscal Year: 2010..We propose to study the impact and cost-effectiveness of an intervention to improve linkage to HIV and TB care for newly diagnosed HIV-infected people in Durban, South Africa. ..